Aurobindo acquires Apotex's operations in 5 European countries
The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses.
The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.
This announcement does not constitute a recommendation to shareholders or potential investors, it added.
Aurobindo Pharma shares were trading 0.94 per cent down at Rs 753.50 apiece on the BSE.
The Economic Times Business News App for the Latest News in Business, Share Market & More.